| Medical and Health Sciences | 2021-2025 | 431 | CN 49 | 99.91 |
| Biological Sciences | 2021-2025 | 701 | CN 251 | 99.25 |
| Agricultural, Food and Veterinary Sciences | 2021-2025 | 874 | CN 298 | 95.66 |
| Mathematics and Statistics | 2021-2025 | 856 | CN 208 | 91.97 |
| Infectious Diseases | Lifetime | 39 | CN 3 | 99.84 |
| Epidemiology | Lifetime | 323 | CN 9 | 99.60 |
| Public, Environmental and Occupational Health | Lifetime | 682 | CN 11 | 99.04 |
| Immunology | Lifetime | 484 | CN 13 | 98.66 |
| Agronomy and Crop Science | Lifetime | 667 | CN 33 | 94.24 |
| Animal Science and Livestock Production | Lifetime | 830 | CN 80 | 91.55 |
| Modeling and Simulation | Lifetime | 372 | CN 66 | 90.41 |
| Virology | Lifetime | 498 | CN 8 | 83.26 |
| Infectious Diseases | 2021-2025 | 4 | CN 1 | 99.89 |
| Epidemiology | 2021-2025 | 100 | CN 12 | 99.37 |
| Molecular Biology | 2021-2025 | 660 | CN 267 | 96.42 |
| Public, Environmental and Occupational Health | 2021-2025 | 423 | CN 16 | 96.08 |
| Immunology | 2021-2025 | 256 | CN 60 | 93.81 |
| Modeling and Simulation | 2021-2025 | 125 | CN 27 | 94.49 |
| Virology | 2021-2025 | 68 | CN 3 | 88.20 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 8 | CN 3 | 99.92 |
| COVID-19 Clinical Research Studies | Lifetime | 14 | CN 4 | 99.88 |
| Viral Infections and Outbreaks Research | Lifetime | 20 | CN 1 | 99.60 |
| Viral gastroenteritis research and epidemiology | Lifetime | 85 | CN 7 | 99.61 |
| Influenza Virus Research Studies | Lifetime | 53 | CN 6 | 99.61 |
| Viral Infections and Vectors | Lifetime | 89 | CN 1 | 99.56 |
| Animal Disease Management and Epidemiology | Lifetime | 79 | CN 4 | 99.39 |
| COVID-19 epidemiological studies | Lifetime | 94 | CN 10 | 99.00 |
| Animal Virus Infections Studies | Lifetime | 161 | CN 15 | 98.99 |
| Respiratory viral infections research | Lifetime | 192 | CN 14 | 99.15 |
| Mosquito-borne diseases and control | Lifetime | 281 | CN 5 | 99.08 |
| Immune Cell Function and Interaction | Lifetime | 757 | CN 19 | 99.04 |
| SARS-CoV-2 detection and testing | Lifetime | 107 | CN 25 | 97.50 |
| Immunotherapy and Immune Responses | Lifetime | 638 | CN 14 | 98.98 |
| Virology and Viral Diseases | Lifetime | 199 | CN 3 | 98.06 |
| interferon and immune responses | Lifetime | 414 | CN 34 | 97.31 |
| vaccines and immunoinformatics approaches | Lifetime | 244 | CN 7 | 97.14 |
| Zoonotic diseases and public health | Lifetime | 461 | CN 13 | 94.36 |
| Bacillus and Francisella bacterial research | Lifetime | 819 | CN 21 | 90.03 |
| Poxvirus research and outbreaks | Lifetime | 780 | CN 13 | 88.09 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 2 | CN 1 | 99.79 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 9 | CN 2 | 99.88 |
| Influenza Virus Research Studies | 2021-2025 | 6 | CN 2 | 99.42 |
| COVID-19 epidemiological studies | 2021-2025 | 18 | CN 5 | 99.24 |
| COVID-19 Clinical Research Studies | 2021-2025 | 69 | CN 9 | 99.54 |
| Animal Virus Infections Studies | 2021-2025 | 26 | CN 10 | 98.00 |
| Viral Infections and Outbreaks Research | 2021-2025 | 17 | CN 2 | 98.44 |
| Zoonotic diseases and public health | 2021-2025 | 23 | CN 3 | 97.56 |
| SARS-CoV-2 detection and testing | 2021-2025 | 78 | CN 14 | 97.64 |
| Viral Infections and Vectors | 2021-2025 | 100 | CN 10 | 97.46 |
| Animal Disease Management and Epidemiology | 2021-2025 | 62 | CN 15 | 97.60 |
| Respiratory viral infections research | 2021-2025 | 131 | CN 7 | 97.35 |
| Immunotherapy and Immune Responses | 2021-2025 | 223 | CN 55 | 96.79 |
| vaccines and immunoinformatics approaches | 2021-2025 | 72 | CN 11 | 95.51 |
| Virus-based gene therapy research | 2021-2025 | 201 | CN 48 | 94.18 |
| Bacillus and Francisella bacterial research | 2021-2025 | 63 | CN 4 | 92.85 |
| Poxvirus research and outbreaks | 2021-2025 | 62 | CN 3 | 94.43 |
| interferon and immune responses | 2021-2025 | 201 | CN 110 | 92.17 |
| Viral Infections and Immunology Research | 2021-2025 | 474 | CN 124 | 88.04 |
| Vector-Borne Animal Diseases | 2021-2025 | 336 | CN 51 | 89.07 |
| Bacteriophages and microbial interactions | 2021-2025 | 919 | CN 224 | 86.54 |
| Immune responses and vaccinations | 2021-2025 | 201 | CN 13 | 82.14 |
| Salmonella and Campylobacter epidemiology | 2021-2025 | 547 | CN 95 | 84.33 |
| Virology and Viral Diseases | 2021-2025 | 387 | CN 62 | 79.83 |
| Vibrio bacteria research studies | 2021-2025 | 706 | CN 210 | 79.15 |
| Immune Response and Inflammation | 2021-2025 | 938 | CN 372 | 74.85 |